{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:32:49Z","timestamp":1792171969643,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["22A-017-0100"],"award-info":[{"award-number":["22A-017-0100"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00381-024-06450-4","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T04:17:00Z","timestamp":1715660220000},"page":"3075-3083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The role of surgery for optic pathway gliomas in the era of precision medicine"],"prefix":"10.1007","volume":"40","author":[{"given":"Joo Whan","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,14]]},"reference":[{"key":"6450_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/archopht.1929.00810010177003","volume":"1","author":"H Cushing","year":"1929","unstructured":"Cushing H, Eisenhardt L (1929) Meningiomas arising from the tuberculum sellae: with the syndrome of primary optic atrophy and bitemporal field defects combined with a normal sella turcica in a middle-aged person. Arch Ophthalmol 1:168\u2013206","journal-title":"Arch Ophthalmol"},{"key":"6450_CR2","first-page":"725","volume":"10","author":"Y Sawamura","year":"2008","unstructured":"Sawamura Y, Kamada K, Kamoshima Y, Yamaguchi S, Tajima T, Tsubaki J, Fujimaki T (2008) Role of surgery for optic pathway\/hypothalamic astrocytomas in children. Neurooncology 10:725\u2013733","journal-title":"Neurooncology"},{"key":"6450_CR3","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00381-021-05060-8","volume":"37","author":"CS Hill","year":"2021","unstructured":"Hill CS, Khan M, Phipps K, Green K, Hargrave D, Aquilina K (2021) Neurosurgical experience of managing optic pathway gliomas. Childs Nerv Syst 37:1917\u20131929","journal-title":"Childs Nerv Syst"},{"key":"6450_CR4","first-page":"1231","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumours of the central nervous system: a summary. Neurooncology 23:1231\u20131251","journal-title":"Neurooncology"},{"key":"6450_CR5","first-page":"iv1","volume":"25","author":"QT Ostrom","year":"2023","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS (2023) CBTRUS Statistical Report: primary brain and other central nervous system tumours diagnosed in the United States in 2016\u20132020. Neurooncology 25:iv1\u2013iv99","journal-title":"Neurooncology"},{"key":"6450_CR6","first-page":"v1","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS (2019) CBTRUS Statistical Report: primary brain and other central nervous system tumours diagnosed in the United States in 2012\u20132016. Neurooncology 21:v1\u2013v100","journal-title":"Neurooncology"},{"key":"6450_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00381-023-05839-x","volume":"39","author":"JW Kim","year":"2023","unstructured":"Kim JW, Phi JH, Kim SK, Lee JH, Park SH, Won JK, Choi JY, Kang HJ, Park CK (2023) Comparison of the clinical features and treatment outcomes of pilocytic astrocytoma in paediatric and adult patients. Childs Nerv Syst 39:583\u2013591","journal-title":"Childs Nerv Syst"},{"key":"6450_CR8","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/FOC-07\/11\/E2","volume":"23","author":"MJ Binning","year":"2007","unstructured":"Binning MJ, Liu JK, Kestle JRW, Brockmeyer DL, Walker ML (2007) Optic pathway gliomas: a review. Neurosurgical Focus FOC 23:E2","journal-title":"Neurosurgical Focus FOC"},{"key":"6450_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/ana.410410204","volume":"41","author":"R Listernick","year":"1997","unstructured":"Listernick R, Louis DN, Packer RJ, Gutmann DH (1997) Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 41:143\u2013149","journal-title":"Ann Neurol"},{"key":"6450_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/adc.87.1.65","volume":"87","author":"S Singhal","year":"2002","unstructured":"Singhal S, Birch JM, Kerr B, Lashford L, Evans DG (2002) Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child 87:65\u201370","journal-title":"Arch Dis Child"},{"key":"6450_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF01050263","volume":"15","author":"EM Housepian","year":"1993","unstructured":"Housepian EM, Linda Chi T (1993) Neurofibromatosis and optic pathways gliomas. J Neurooncol 15:51\u201355","journal-title":"J Neurooncol"},{"key":"6450_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0887-8994(02)00628-8","volume":"28","author":"SL Tow","year":"2003","unstructured":"Tow SL, Chandela S, Miller NR, Avellino AM (2003) Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol 28:262\u2013270","journal-title":"Pediatr Neurol"},{"key":"6450_CR13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S1470-2045(19)30277-3","volume":"20","author":"J Fangusaro","year":"2019","unstructured":"Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Qaddoumi I, Jakacki RI, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M (2019) Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol 20:1011\u20131022","journal-title":"Lancet Oncol"},{"key":"6450_CR14","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1200\/JCO.1993.11.5.850","volume":"11","author":"RJ Packer","year":"1993","unstructured":"Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R, Prados M, Jakacki R, Reaman G, Needles MN et al (1993) Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11:850\u2013856","journal-title":"J Clin Oncol"},{"key":"6450_CR15","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3171\/jns.1997.86.5.0747","volume":"86","author":"RJ Packer","year":"1997","unstructured":"Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, Jakacki R, Kurczynski E, Needle M, Finlay J, Reaman G, Boyett JM (1997) Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86:747\u2013754","journal-title":"J Neurosurg"},{"key":"6450_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/neuonc\/2.4.213","volume":"2","author":"DH Mahoney Jr","year":"2000","unstructured":"Mahoney DH Jr., Cohen ME, Friedman HS, Kepner JL, Gemer L, Langston JW, James HE, Duffner PK, Kun LE (2000) Carboplatin is effective therapy for young children with progressive optic pathway tumours: a Paediatric Oncology Group phase II study. Neuro Oncol 2:213\u2013220","journal-title":"Neuro Oncol"},{"key":"6450_CR17","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1200\/JCO.2011.36.6054","volume":"30","author":"JL Ater","year":"2012","unstructured":"Ater JL, Zhou T, Holmes E, Mazewski CM, Booth TN, Freyer DR, Lazarus KH, Packer RJ, Prados M, Sposto R, Vezina G, Wisoff JH, Pollack IF (2012) Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children\u2019s Oncology Group. J Clin Oncol 30:2641\u20132647","journal-title":"J Clin Oncol"},{"key":"6450_CR18","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ijrobp.2017.07.023","volume":"99","author":"DS Tsang","year":"2017","unstructured":"Tsang DS, Murphy ES, Merchant TE (2017) Radiation therapy for optic pathway and hypothalamic low-grade gliomas in children. Int J Radiat Oncol Biol Phys 99:642\u2013651","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6450_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0090-3019(87)90309-0","volume":"28","author":"GR Gillett","year":"1987","unstructured":"Gillett GR, Symon L (1987) Hypothalamic glioma. Surg Neurol 28:291\u2013300","journal-title":"Surg Neurol"},{"key":"6450_CR20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3171\/jns.1990.73.5.0661","volume":"73","author":"JH Wisoff","year":"1990","unstructured":"Wisoff JH, Abbott R, Epstein F (1990) Surgical management of exophytic chiasmatic-hypothalamic tumours of childhood. J Neurosurg 73:661\u2013667","journal-title":"J Neurosurg"},{"key":"6450_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF01405505","volume":"130","author":"A Konovalov","year":"1994","unstructured":"Konovalov A, Gorelyshev S, Serova N (1994) Surgery of giant gliomas of chiasma and IIIrd ventricle. Acta Neurochir (Wien) 130:71\u201379","journal-title":"Acta Neurochir (Wien)"},{"key":"6450_CR22","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s00381-006-0086-7","volume":"22","author":"Y Ahn","year":"2006","unstructured":"Ahn Y, Cho BK, Kim SK, Chung YN, Lee CS, Kim IH, Yang SW, Kim HS, Kim HJ, Jung HW, Wang KC (2006) Optic pathway glioma: outcome and prognostic factors in a surgical series. Childs Nerv Syst 22:1136\u20131142","journal-title":"Childs Nerv Syst"},{"key":"6450_CR23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3171\/jns.1995.83.4.0583","volume":"83","author":"LN Sutton","year":"1995","unstructured":"Sutton LN, Molloy PT, Sernyak H, Goldwein J, Phillips PL, Rorke LB, Moshang T, Lange B, Packer RJ (1995) Long-term outcome of hypothalamic\/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg 83:583\u2013589","journal-title":"J Neurosurg"},{"key":"6450_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1227\/01.NEU.0000097266.89676.25","volume":"54","author":"RJ Komotar","year":"2004","unstructured":"Komotar RJ, Burger PC, Carson BS, Brem H, Olivi A, Goldthwaite PT, Tihan T (2004) Pilocytic and pilomyxoid hypothalamic\/chiasmatic astrocytomas. Neurosurgery 54:72\u201380","journal-title":"Neurosurgery"},{"key":"6450_CR25","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.ejca.2006.02.022","volume":"42","author":"E Opocher","year":"2006","unstructured":"Opocher E, Kremer LC, Da Dalt L, van de Wetering MD, Viscardi E, Caron HN, Perilongo G (2006) Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer 42:1807\u20131816","journal-title":"Eur J Cancer"},{"key":"6450_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1023\/B:NEON.0000041877.14749.b6","volume":"69","author":"JT Rutka","year":"2004","unstructured":"Rutka JT, Kuo JS (2004) Paediatric surgical neuro-oncology: current best care practices and strategies. J Neurooncol 69:139\u2013150","journal-title":"J Neurooncol"},{"key":"6450_CR27","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/neuonc\/nos330","volume":"15","author":"DA Walker","year":"2013","unstructured":"Walker DA, Liu J, Kieran M, Jabado N, Picton S, Packer R, St Rose C (2013) A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method. Neuro Oncol 15:462\u2013468","journal-title":"Neuro Oncol"},{"key":"6450_CR28","doi-asserted-by":"publisher","first-page":"e451","DOI":"10.1016\/j.wneu.2022.07.018","volume":"166","author":"JW Kim","year":"2022","unstructured":"Kim JW, Phi JH, Lee JY, Koh EJ, Kim KH, Kang HJ, Choi JY, Park SH, Wang KC, Kim SK (2022) Clinical outcome of optic pathway and hypothalamic gliomas: a 20-year single-institution retrospective study. World Neurosurg 166:e451\u2013e459","journal-title":"World Neurosurg"},{"key":"6450_CR29","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/ng.2611","volume":"45","author":"J Zhang","year":"2013","unstructured":"Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B, Orisme W, Punchihewa C, Parker M, Qaddoumi I, Boop FA, Lu C, Kandoth C, Ding L, Lee R, Huether R, Chen X, Hedlund E, Nagahawatte P, Rusch M, Boggs K, Cheng J, Becksfort J, Ma J, Song G, Li Y, Wei L, Wang J, Shurtleff S, Easton J, Zhao D, Fulton RS, Fulton LL, Dooling DJ, Vadodaria B, Mulder HL, Tang C, Ochoa K, Mullighan CG, Gajjar A, Kriwacki R, Sheer D, Gilbertson RJ, Mardis ER, Wilson RK, Downing JR, Baker SJ, Ellison DW (2013) Whole-genome sequencing identifies genetic alterations in paediatric low-grade gliomas. Nat Genet 45:602\u2013612","journal-title":"Nat Genet"},{"key":"6450_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/cancers13040607","volume":"13","author":"JY Tan","year":"2021","unstructured":"Tan JY, Wijesinghe IVS, Alfarizal Kamarudin MN, Parhar I (2021) Paediatric gliomas: BRAF and histone H3 as biomarkers, therapy and perspective of liquid biopsies. Cancers 13:607","journal-title":"Cancers"},{"key":"6450_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40478-020-00902-z","volume":"8","author":"S Ryall","year":"2020","unstructured":"Ryall S, Tabori U, Hawkins C (2020) Paediatric low-grade glioma in the era of molecular diagnostics. Acta Neuropathol Commun 8:30","journal-title":"Acta Neuropathol Commun"},{"key":"6450_CR32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","volume":"121","author":"G Schindler","year":"2011","unstructured":"Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, Schmieder K, Wesseling P, Mawrin C, Hasselblatt M, Louis DN, Korshunov A, Pfister S, Hartmann C, Paulus W, Reifenberger G, von Deimling A (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumours reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121:397\u2013405","journal-title":"Acta Neuropathol"},{"key":"6450_CR33","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1200\/JCO.2016.71.8726","volume":"35","author":"A Lassaletta","year":"2017","unstructured":"Lassaletta A, Zapotocky M, Mistry M, Ramaswamy V, Honnorat M, Krishnatry R, Guerreiro Stucklin A, Zhukova N, Arnoldo A, Ryall S, Ling C, McKeown T, Loukides J, Cruz O, de Torres C, Ho CY, Packer RJ, Tatevossian R, Qaddoumi I, Harreld JH, Dalton JD, Mulcahy-Levy J, Foreman N, Karajannis MA, Wang S, Snuderl M, Nageswara Rao A, Giannini C, Kieran M, Ligon KL, Garre ML, Nozza P, Mascelli S, Raso A, Mueller S, Nicolaides T, Silva K, Perbet R, Vasiljevic A, Faure Conter C, Frappaz D, Leary S, Crane C, Chan A, Ng HK, Shi ZF, Mao Y, Finch E, Eisenstat D, Wilson B, Carret AS, Hauser P, Sumerauer D, Krskova L, Larouche V, Fleming A, Zelcer S, Jabado N, Rutka JT, Dirks P, Taylor MD, Chen S, Bartels U, Huang A, Ellison DW, Bouffet E, Hawkins C, Tabori U (2017) Therapeutic and prognostic implications of BRAF V600E in paediatric low-grade gliomas. J Clin Oncol 35:2934\u20132941","journal-title":"J Clin Oncol"},{"key":"6450_CR34","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s00381-020-04724-1","volume":"36","author":"CS Hill","year":"2020","unstructured":"Hill CS, Devesa SC, Ince W, Borg A, Aquilina K (2020) A systematic review of ongoing clinical trials in optic pathway gliomas. Childs Nerv Syst 36:1869\u20131886","journal-title":"Childs Nerv Syst"},{"key":"6450_CR35","first-page":"528","volume":"24","author":"LJ Andrews","year":"2021","unstructured":"Andrews LJ, Thornton ZA, Saincher SS, Yao IY, Dawson S, McGuinness LA, Jones HE, Jefferies S, Short SC, Cheng H-Y, McAleenan A, Higgins JPT, Kurian KM (2021) Prevalence of BRAFV600 in glioma and use of BRAF inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review. Neurooncology 24:528\u2013540","journal-title":"Neurooncology"},{"key":"6450_CR36","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.1158\/1078-0432.CCR-19-2177","volume":"25","author":"DR Hargrave","year":"2019","unstructured":"Hargrave DR, Bouffet E, Tabori U, Broniscer A, Cohen KJ, Hansford JR, Geoerger B, Hingorani P, Dunkel IJ, Russo MW, Tseng L, Dasgupta K, Gasal E, Whitlock JA, Kieran MW (2019) Efficacy and safety of dabrafenib in paediatric patients with BRAF V600 mutation-positive relapsed or refractory low-grade glioma: results from a phase I\/IIa study. Clin Cancer Res 25:7303\u20137311","journal-title":"Clin Cancer Res"},{"key":"6450_CR37","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0140-6736(15)60898-4","volume":"386","author":"GV Long","year":"2015","unstructured":"Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Grob JJ, Chiarion-Sileni V, Lebbe C, Mandal\u00e0 M, Millward M, Arance A, Bondarenko I, Haanen JB, Hansson J, Utikal J, Ferraresi V, Kovalenko N, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, DeMarini DJ, Irani JG, Swann S, Legos JJ, Jin F, Mookerjee B, Flaherty K (2015) Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial. Lancet 386:444\u2013451","journal-title":"Lancet"},{"key":"6450_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1470-2045(21)00578-7","volume":"23","author":"PY Wen","year":"2022","unstructured":"Wen PY, Stein A, van den Bent M, De Greve J, Wick A, de Vos FYFL, von Bubnoff N, van Linde ME, Lai A, Prager GW, Campone M, Fasolo A, Lopez-Martin JA, Kim TM, Mason WP, Hofheinz R-D, Blay J-Y, Cho DC, Gazzah A, Pouessel D, Yachnin J, Boran A, Burgess P, Ilankumaran P, Gasal E, Subbiah V (2022) Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial. Lancet Oncol 23:53\u201364","journal-title":"Lancet Oncol"},{"key":"6450_CR39","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1056\/NEJMoa2303815","volume":"389","author":"E Bouffet","year":"2023","unstructured":"Bouffet E, Hansford JR, Garr\u00e8 ML, Hara J, Plant-Fox A, Aerts I, Locatelli F, van der Lugt J, Papusha L, Sahm F, Tabori U, Cohen KJ, Packer RJ, Witt O, Sandalic L, Pereira Bento, da, Silva A, Russo M, Hargrave DR, (2023) Dabrafenib plus trametinib in paediatric glioma with BRAF V600 mutations. N Engl J Med 389:1108\u20131120","journal-title":"N Engl J Med"},{"key":"6450_CR40","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","volume":"375","author":"E Dombi","year":"2016","unstructured":"Dombi E, Baldwin A, Marcus LJ, Fisher MJ, Weiss B, Kim A, Whitcomb P, Martin S, Aschbacher-Smith LE, Rizvi TA, Wu J, Ershler R, Wolters P, Therrien J, Glod J, Belasco JB, Schorry E, Brofferio A, Starosta AJ, Gillespie A, Doyle AL, Ratner N, Widemann BC (2016) Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas. N Engl J Med 375:2550\u20132560","journal-title":"N Engl J Med"},{"key":"6450_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41591-023-02668-y","volume":"30","author":"LB Kilburn","year":"2024","unstructured":"Kilburn LB, Khuong-Quang DA, Hansford JR, Landi D, van der Lugt J, Leary SES, Driever PH, Bailey S, Perreault S, McCowage G, Waanders AJ, Ziegler DS, Witt O, Baxter PA, Kang HJ, Hassall TE, Han JW, Hargrave D, Franson AT, Yalon Oren M, Toledano H, Larouche V, Kline C, Abdelbaki MS, Jabado N, Gottardo NG, Gerber NU, Whipple NS, Segal D, Chi SN, Oren L, Tan EEK, Mueller S, Cornelio I, McLeod L, Zhao X, Walter A, Da Costa D, Manley P, Blackman SC, Packer RJ, Nysom K (2024) The type II RAF inhibitor tovorafenib in relapsed\/refractory paediatric low-grade glioma: the phase 2 FIREFLY-1 trial. Nat Med 30:207\u2013217","journal-title":"Nat Med"},{"key":"6450_CR42","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1093\/neuonc\/noab164","volume":"23","author":"V Ramaswamy","year":"2021","unstructured":"Ramaswamy V, Bartels U (2021) Selumetinib for optic pathway glioma: seeing through the fog, (not yet) the end of the tunnel? Neuro Oncol 23:1627\u20131628","journal-title":"Neuro Oncol"},{"key":"6450_CR43","doi-asserted-by":"publisher","first-page":"884250","DOI":"10.3389\/fsurg.2022.884250","volume":"9","author":"DC Samples","year":"2022","unstructured":"Samples DC, Mulcahy Levy JM, Hankinson TC (2022) Neurosurgery for optic pathway glioma: optimizing multidisciplinary management. Front Surg 9:884250","journal-title":"Front Surg"},{"key":"6450_CR44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11060-015-1722-4","volume":"122","author":"M Ge","year":"2015","unstructured":"Ge M, Li S, Wang L, Li C, Zhang J (2015) The role of diffusion tensor tractography in the surgical treatment of paediatric optic chiasmatic gliomas. J Neurooncol 122:357\u2013366","journal-title":"J Neurooncol"},{"key":"6450_CR45","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s10143-020-01371-7","volume":"44","author":"M Birski","year":"2021","unstructured":"Birski M, Furtak J, Krystkiewicz K, Birska J, Zielinska K, Sokal P, Rusinek M, Paczkowski D, Szylberg L, Harat M (2021) Endoscopic versus stereotactic biopsies of intracranial lesions involving the ventricles. Neurosurg Rev 44:1721\u20131727","journal-title":"Neurosurg Rev"},{"key":"6450_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2013.8.PEDS12546","volume":"13","author":"J Goodden","year":"2014","unstructured":"Goodden J, Pizer B, Pettorini B, Williams D, Blair J, Didi M, Thorp N, Mallucci C (2014) The role of surgery in optic pathway\/hypothalamic gliomas in children. J Neurosurg Pediatr 13:1\u201312","journal-title":"J Neurosurg Pediatr"},{"key":"6450_CR47","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s00381-020-04719-y","volume":"36","author":"J Roth","year":"2020","unstructured":"Roth J, Constantini S, Cinalli G (2020) Neurofibromatosis type 1\u2013related hydrocephalus: causes and treatment considerations. Child\u2019s Nerv Syst 36:2385\u20132390","journal-title":"Child\u2019s Nerv Syst"},{"key":"6450_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11102-021-01181-0","volume":"25","author":"H Kang","year":"2022","unstructured":"Kang H, Kim KM, Kim MS, Kim JH, Park CK, Kim YH (2022) Safety of endoscopic endonasal biopsy for the pituitary stalk-hypothalamic lesions. Pituitary 25:143\u2013151","journal-title":"Pituitary"},{"key":"6450_CR49","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3340\/jkns.2020.0231","volume":"64","author":"Y-H Kim","year":"2021","unstructured":"Kim Y-H, Kang H, Dho Y-S, Hwang K, Joo J-D, Kim YH (2021) Multi-layer onlay graft using hydroxyapatite cement placement without cerebrospinal fluid diversion for endoscopic skull base reconstruction. J Korean Neurosurg Soc 64:619\u2013630","journal-title":"J Korean Neurosurg Soc"},{"key":"6450_CR50","doi-asserted-by":"publisher","first-page":"769576","DOI":"10.3389\/fonc.2022.769576","volume":"12","author":"J Yang","year":"2022","unstructured":"Yang J, Kim YH, Phi JH, Kim SK, Wang KC (2022) Complications of endoscopic skull base surgery for sellar and parasellar tumours in pediatric population; neurosurgical perspectives. Front Oncol 12:769576","journal-title":"Front Oncol"},{"key":"6450_CR51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3340\/jkns.2017.0101.002","volume":"60","author":"WS Cho","year":"2017","unstructured":"Cho WS, Kim JE, Kang HS, Son YJ, Bang JS, Oh CW (2017) Keyhole approach and neuroendoscopy for cerebral aneurysms. J Korean Neurosurg Soc 60:275\u2013281","journal-title":"J Korean Neurosurg Soc"},{"key":"6450_CR52","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.wneu.2016.02.042","volume":"89","author":"MA El Beltagy","year":"2016","unstructured":"El Beltagy MA, Reda M, Enayet A, Zaghloul MS, Awad M, Zekri W, Taha H, El-Khateeb N (2016) Treatment and outcome in 65 children with optic pathway gliomas. World Neurosurg 89:525\u2013534","journal-title":"World Neurosurg"},{"key":"6450_CR53","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.wneu.2017.09.144","volume":"109","author":"Y Liu","year":"2018","unstructured":"Liu Y, Hao X, Liu W, Li C, Gong J, Ma Z, Tian Y (2018) Analysis of survival prognosis for children with symptomatic optic pathway gliomas who received surgery. World Neurosurg 109:e1\u2013e15","journal-title":"World Neurosurg"},{"key":"6450_CR54","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3171\/2012.7.PEDS1270","volume":"10","author":"RM Lober","year":"2012","unstructured":"Lober RM, Guzman R, Cheshier SH, Fredrick DR, Edwards MS, Yeom KW (2012) Application of diffusion tensor tractography in paediatric optic pathway glioma. J Neurosurg Pediatr 10:273\u2013280","journal-title":"J Neurosurg Pediatr"},{"key":"6450_CR55","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3340\/jkns.2018.0078","volume":"61","author":"K Kim","year":"2018","unstructured":"Kim K, Cho C, Bang MS, Shin HI, Phi JH, Kim SK (2018) Intraoperative neurophysiological monitoring: a review of techniques used for brain tumour surgery in children. J Korean Neurosurg Soc 61:363\u2013375","journal-title":"J Korean Neurosurg Soc"},{"key":"6450_CR56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s003810100460","volume":"17","author":"Z Gil","year":"2001","unstructured":"Gil Z, Beni-Adani L, Siomin V, Nagar H, Dvir R, Constantini S (2001) Ascites following ventriculoperitoneal shunting in children with chiasmatic-hypothalamic glioma. Childs Nerv Syst 17:395\u2013398","journal-title":"Childs Nerv Syst"},{"key":"6450_CR57","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000120846","volume":"21","author":"A West","year":"2008","unstructured":"West A, Berger MS, Geyer R (2008) Childhood optic pathway tumours associated with ascites following ventriculoperitoneal shunt placement. Pediatr Neurosurg 21:254\u2013259","journal-title":"Pediatr Neurosurg"},{"key":"6450_CR58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/neuonc\/noad195","volume":"26","author":"J Fangusaro","year":"2024","unstructured":"Fangusaro J, Jones DT, Packer RJ, Gutmann DH, Milde T, Witt O, Mueller S, Fisher MJ, Hansford JR, Tabori U, Hargrave D, Bandopadhayay P (2024) Paediatric low-grade glioma: state-of-the-art and ongoing challenges. Neuro Oncol 26:25\u201337","journal-title":"Neuro Oncol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-024-06450-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-024-06450-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-024-06450-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T07:10:46Z","timestamp":1729840246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-024-06450-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,14]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["6450"],"URL":"https:\/\/doi.org\/10.1007\/s00381-024-06450-4","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,14]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}